All research papers

Liver stereotactic body radiation therapy without fiducial or retained ethiodized oil guidance warrants greater than 5 mm planning target volumes.

Phase I clinical evaluation of 99m Tc-labeled Affibody molecule for imaging HER2 expression in breast cancer.

A total inverse planning paradigm: Prospective clinical trial evaluating the performance of a novel MR-based 3D-printed head immobilization device.

Radiation exposure of Staff handling ¹⁸Fluorine-Fluorodeoxyglucose in a new positron emission tomography/computed tomography centre.

Simultaneous photon counting and charge integrating for pulse pile-up correction in paralyzable photon counting detectors.

Mono iso-centric VMAT planning for SBRT of multiple liver metastasis- A case report.

Patient Dose Analysis Using GafchromicTM EBT3 Film: A Retrospective Study with a Four Dual-Field Technique in Total Skin Electron Therapy.

AAPM Task Group Report 307: Use of EPIDs for Patient-Specific IMRT and VMAT QA.

Functional PET Neuroimaging in Consciousness Evaluation: Study Protocol.

ESTRO-ACROP guideline: Recommendations on implementation of breath-hold techniques in radiotherapy.

Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities.

Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer.

Mask dependency of the lacrimal gland dose under whole brain radiotherapy when the six-degrees of freedom couch is not available.

Stereotactic radiosurgery for medium and large uveal melanoma with a non-invasive eye immobilization device, a single institutional case series.

Joint EANM/SNMMI procedure guideline for the use of ¹⁷⁷Lu-labeled PSMA-targeted radioligand-therapy (¹⁷⁷Lu-PSMA-RLT).

Towards quantitative in vivo dosimetry using x-ray acoustic computed tomography.

Quantification of six-degree-of-freedom motion during beam delivery in spine stereotactic body radiotherapy using intra-irradiation cone-beam computed tomography imaging technique.

Extremity dosimetry for exposed workers in positron emission tomography in Bosnia and Herzegovina.

In Vivo Dosimetry in the Urethra During Prostate Carbon Ion Radiotherapy.

FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer.

Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment.

The use of in-vivo dosimetry to identify head and neck cancer patients needing adaptive radiotherapy.

The application of gradient dose segmented analysis of in-vivo EPID images for patients undergoing VMAT in a resource-constrained environment.

The spatial accuracy of ring-mounted halcyon linac versus C-arm TrueBeam linac for single-isocenter/multi-target SBRT treatment.

Feasibility of online radial magnetic resonance imaging for adaptive radiotherapy of pancreatic tumors.

Feasibility and Safety of Tailored Lymphadenectomy Using Sentinel Node-Navigated Surgery in Patients with High-Risk T1 Esophageal Adenocarcinoma.

Occupational exposure to ionizing radiation in medical staff: trends during the 2009-2019 period in a multicentric study.

Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2).

Selective de-implementation of routine in vivo dosimetry.

Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study.

Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies.

Implementation of superficial radiation therapy (SRT) using SRT-100 Vision™ for non-melanoma skin cancer in a Radiation Oncology clinic.

Radiolysis-Associated Decrease in Radiochemical Purity of ¹⁷⁷Lu-Radiopharmaceuticals and Comparison of the Effectiveness of Selected Quenchers against This Process.

Automated synthesis and quality control of [⁶⁸Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imaging.

Assessing the impact of adaptations to the clinical workflow in radiotherapy using transit in vivo dosimetry.

Technical note: Investigating the suitability of existing facilities for a new Lu-177 prostate-specific membrane antigen therapy program.

Sentinel Lymph Node Procedure in Pediatric Patients with Melanoma, Squamous Cell Carcinoma, or Sarcoma Using Near-Infrared Fluorescence Imaging with Indocyanine Green: A Feasibility Trial.

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.

Main challenges in radiation protection with emerging radionuclide therapies.

FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease.

A preclinical model to investigate normal tissue damage following fractionated radiotherapy to the head and neck.

Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases.

Machine performance and stability of the first clinical self-shielded stereotactic radiosurgery system: Initial 2-year experience.

Error detection using EPID-based 3D in vivo dose verification for lung stereotactic body radiotherapy.

Preliminary Screening of Soils Natural Radioactivity and Metal(loid) Content in a Decommissioned Rare Earth Elements Processing Plant, Guangdong, China.

Evaluation of setup errors of immobilization device for radiation therapy in companion animals.

Results from the AAPM Task Group 324 respiratory motion management in radiation oncology survey.

Good practices for ⁶⁸Ga radiopharmaceutical production.

[¹⁷⁷Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer.

PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [¹⁷⁷Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial.

Assessment of emission data and transmission factors supporting radiation protection in the use of ²²⁵Ac.

Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities.

The fast calibration model for dosimetry with an electronic portal imaging device.

Recurrent environmental contamination in a centralized radiopharmacy unit by Achromobacter spp: Results of a large microbiological investigation.

Commissioning an Exradin W2 plastic scintillation detector for clinical use in small radiation fields.

Accuracy and consistency of intensity-based deformable image registration in 4DCT for tumor motion estimation in liver radiotherapy planning.

Head-to-Head Comparison of [⁶⁸ Ga]Ga-FAPI-46-PET/CT and [¹⁸F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer.

Evaluation of the Hybrid Tracer Indocyanine Green- 99m Tc-Nanocolloid for Sentinel Node Biopsy in Bladder Cancer-A Prospective Pilot Study.

Very-Low-Dose Radiation and Clinical Molecular Nuclear Medicine.

Analysis of Pros and Cons in Using [⁶⁸Ga]Ga-PSMA-11 and [¹⁸F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer.